Explore the groundbreaking intersection of AI and cannabis with our latest blog. From CannManage.AI’s pioneering AI solutions for the cannabis industry to the latest in AI-controlled cultivation and impairment detection, we explore diverse innovations transforming this space. Discussions about AI’s role in supply chain optimization, disease research, and even robotic joint rolling highlight how this technology is already reshaping the cannabis landscape, with 2024 poised to become the dawn of the generative AI rush.
The dawn of generative/conversational and robotic AI innovations will aim to nurture efficiency and organization, with some promising revolutions at the top of the queue. Cannabis plant-touching and tech companies in the past have raised significant funding only to fail or downsize significantly due to a lack of technical knowledge in running the type of companies they are trying to implement their product within. Case studies may support applicability within specific facilities but speak nothing of scalability.
CannManage.AI Launches The Cannabis Industry’s First Full-Service AI Solutions and Training Company
Adapting any cannabis business with artificial intelligence in the space involves enjoining two nascent trades. CannManage.AI, the newest wing of the CannManage technical writing and consulting firm, aims to serve as a bridge. Keeping the cannabis industry informed about artificial intelligence and generative AI advancements that may enhance the trade while also having the capacity to create customized solutions for cannabis businesses. They have partnered with experienced developers to leverage the extensive CannManage content database accumulated over the CEO’s 16-year history in the trade to create or implement existing real-time solutions.
These services will extend to cannabis consultants, creatives, authors, law firms, plant-touching, and ancillary companies looking to redefine content strategy and explore custom business automation options. CannManage will also partner with and support AI companies in their journey to create a Culture of Accountability in the cannabis trade. AI can lessen your mundane workload and replace it with enacting real change in this space.
Contact Us To Discuss AI Solutions For Your Company: https://calendly.com/bethcann/visionintake
Join Our Cannmanage AI LinkedIn Group: https://www.linkedin.com/groups/14348444/
Sign Up Here For Our Newsletter: To subscribe, scroll to the bottom of http://www.cannmanage.ai
AI Retail Supply Chain Solutions – Prelude Raises $5.2M In Seed Round
Prelude, an emerging company at the intersection of AI and the cannabis industry, announced on November 28, 2023, a $5.2 million seed funding round. This investment, led by Rackhouse Ventures and Casa Verde, underscores the growing interest in integrating advanced technologies into the cannabis sector. The funding is earmarked for developing an AI-powered supply chain solution, a first in this domain. This initiative represents a significant advancement in addressing the cannabis industry’s complex supply chain challenges. By leveraging AI, Prelude aims to optimize inventory management for cannabis retailers, a critical aspect given the industry’s unique regulatory and financial constraints. The technology focuses on data-driven decision-making, enabling dispensaries to make informed choices about product assortments and stock levels, enhancing efficiency and profitability. The founders, Michael E. Murphy and Andrew Copp blend retail and technology expertise.
HyperScale Nexus Hoards GPUs Without Explanation
In late October of 2023, HyperScale Nexus holding corporation was acquired by Colorado-based American Cannabis Company. HyperScale Nexus was a company that had centered itself around the Nvidia H100 GPU chipsets. GPUs are critical to the AI industry, and these graphics processing units are crucial components for deep learning training, speed and efficiency, and adaptability to increasingly complex models. Nvidia is an industry leader in AI, particularly its ability to manufacture high-quality components such as GPUs. While there is no clear explanation as to why a cannabis company would acquire a separate entity that is seemingly unrelated, mainly as both will operate independently, the possibilities are intriguing.
AI-Controlled Cultivation Environment
While the term ‘controlled environmental agriculture’ might seem unfamiliar to many, it’s increasingly becoming a crucial methodology, especially in the face of climate change, when paired with vertical farming, to ensure efficient year-round yields. In the cannabis industry, this approach has direct applications. An article from MJBizDaily, featuring insights from Kenneth Tran, CEO of the Seattle-based startup Koidra, sheds light on this innovative approach.
Tran’s model draws inspiration from Cornell University’s and Neil Mattson’s controlled environmental engineering framework and offers two distinct approaches. One is centered around the greenhouse’s structure, while the other is tailored to the cultivated crops. This approach creates a 3D representation of the cultivation site, enabling precise programming of environmental controls, including light, temperature, humidity, and more. While similar programs exist for various crops, interestingly, there hasn’t been a specific one developed for cannabis cultivation yet.
Tran suggests that adapting such a program for cannabis would be a relatively straightforward task and could potentially make optimizing the yields of cannabis harvests a natural occurrence. Industry-wide, this has tremendous potential. With AI technology such as the preceding adopted, the days of uncertainty are gone. Now, cultivators can use this technology to produce consistently reliable harvests.
Detecting Cannabis Impairment
The Canadian-based company Predictmedix (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) has developed an AI mobile solution for the impairment of both alcohol and cannabis. Their technology uses a multi-spectrum camera to detect the signs of impairment non-invasively. Typical features that are associated with impairment are passed through their AI algorithm to make a final assessment.
AI can also be found outside of the cultivation facility; as stated, its applications, in the proper hands, are essentially limitless. In the medical world, where many are introduced to cannabis either academically or physically, various conditions are being evaluated along with their response to cannabis.
Detecting Illness
Alzheimer’s Disease affects millions of people worldwide with no current known cure. IGC Pharma has worked on groundbreaking research and is implementing a potential solution. IGC Pharma has developed a new pharmaceutical, IGC-AD1. IGC-AD1 is delivered as a low-dose THC medication in oral form; each individual will respond differently, ideally in a way that means that they can manage their symptoms of Alzheimer’s disease in an improved format for a greater quality of life. Essentially, this medication starts its life like any other concentrate; organically, it is grown flower that is later refined to a high potency THC concentrate that is subsequently diluted for its pharmaceutical dosage.
Their AI-driven algorithms will be used to analyze the data on the company’s internal software, developed primarily to capture neuropsychiatric symptoms in AD patients.
This particular formulation is novel in what it can assist in producing, increasing spatial memory (the memory of the location of objects), preventing the formation of plaques (clumps of protein between brain cells), tangles within neurons that cause memory loss, and increases mitochondrial (the power center of a cell) functioning. It is a groundbreaking drug that has the potential to assist millions.
Those who developed the technology also set the proper algorithms – an essential procedure for performing a computation – and with a knowledge base in the world of medical research, they were able to develop those that can capture neuropsychiatric symptoms. These are the symptoms that cover both neurology and psychology, key indicators of Alzheimer’s disease.
Joint Rolling Robots
The company PreRoll-ER is part science and part craft. The company has an innovative AI process that can best anyone’s efficacy in rolling. PreRoll-ER has been an effective solution in providing CBD joints at a rate of over a million per month, that’s over three thousand a day. While this technology might save the dexterity of those in the back of the house, this technology has ever-reaching implications. This is a technology that can only increase the efficacy of the cannabis industry. It can adhere to regulatory standards, even going as far as to add the excise tax label for the Canadian market. Industry-wise, the implications are optimal: more hands-free budtenders and manufacturing staff who can openly share their knowledge about cannabis with the consumer, and adherence to regulatory standards can be satisfied without worry.
MDAppBud – Beta Application Assistant by CannManage.ai
Cannmanage.ai developed an OpenAI-backed conversational chatbot, MDAppBud, to assist clients with application licensing in Maryland. This product is available for demo. Additional products in early 2024 to help companies further in this facet of the trade will be released soon.